NEW YORK, April 20, 2020 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and ...
The environmental problems caused by adverse effects of plastics and other materials has increased interest for bio-based materials. In this context, projects such as the EU funded BioMonitor set out ...
Redwood City, Calif.-based startup Heartflow Inc. has received a new technology ambulatory payment classification (APC) for its FFRct Analysis. This is an FDA-cleared, novel, noninvasive, coronary ...
The FDA has issued new risk classification orders for two series of products, including in vitro diagnostics for hepatitis C, two of which the agency down-regulated from class III to class II. However ...
Statistical classifications generally follow relevant policy and societal trends. There are therefore opportunities to add statistical codes for bio-based products and materials to statistical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback